参考文献/References:
[1]李鲁,张迪,杨淑彬.血清胆红素、尿酸联合同型半胱氨酸检测对冠心病的诊断价值[J].陕西医学杂志,2022,51(12):1589-1592.[2]蒋薇,闵祖良,刘杰杰,等.老年冠状动脉粥样硬化性心脏病患者TBIL、HCY、Hs-CRP、UA水平与冠状动脉不稳定性斑块形成风险的关系[J].中国急救复苏与灾害医学杂志,2022,17(3):304-308.[3]张倩,袁静,徐小英,等.血清TBIL、Hcy、hs-CRP、UA水平与老年冠心病病人冠状动脉不稳定性斑块形成间的关系[J].实用老年医学,2022,36(1):77-80.[4]杨晓东,饶丽华,代艳文,等.同型半胱氨酸、脂蛋白a及尿酸单独或联合检测在冠心病诊疗监测中的应用研究[J].标记免疫分析与临床,2021,28(8):1366-1370.[5]李健,况宇,秦维超.血清胆红素与尿酸在冠心病患者中的水平变化及诊断价值[J].检验医学与临床,2020,17(24):3632-3634.[6]戢少祎,张湘瑜,罗荧荃.血清相关指标联合检测对冠心病诊断及预后的评估价值[J].中华老年心脑血管病杂志,2020,22(7):707-709.[7]董茜,韩晓涛,陈永福,等.不同类型冠心病患者血清Hcy、TBIL、hs-CRP、尿酸的表达及临床意义[J].现代生物医学进展,2020,20(9):1669-1672.[8]中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.稳定性冠心病诊断与治疗指南[J].中华心血管病杂志,2018,46(9):680-694.[9]周春娟,毛文娟,王瑜硕,等.冠心病患者血清脂蛋白、血尿酸水平与冠脉狭窄程度的相关性[J].海南医学,2019,30(24):3152-3155.[10]秦伟彬,何贵新,林琳,等.不同尿酸水平老年冠心病患者血管内超声检查结果比较研究[J].中国全科医学,2020,23(6):656-661.[11]徐萃,刘宏斌,王娟,等.血清尿酸水平与冠心病患者远期预后的分析[J].解放军医学院学报,2018,39(2):102-105,109.[12]郭小宏,汪涛.老年冠心病患者同型半胱氨酸、总胆红素水平与颈动脉硬化的相关性[J].实用医学杂志,2019,35(19):3048-3052.[13]刘善宽,尹俊明.PCT、CRP、血清胆红素、尿酸及载脂蛋白A1、B对冠心病的诊断价值[J].广东医学,2019,40(15):2246-2248,2253.[14]耿学斌,李莉,马燚,等.血清胆红素与心绞痛患者冠状动脉病变程度和预后的关系[J].中国动脉硬化杂志,2019,27(3):236-240,253.[15]杨辉,邵名亮,方存明,等.血清胆红素和尿酸水平与冠心病的相关分析[J].贵州医药,2018,42(8):960-962.[16]王君,席新龙,赵棉.尿酸与冠心病、血压、血脂及体重指数的相关性研究[J].陕西医学杂志,2018,47(8):1032-1035.[17]刘子铭,李凯勇,张诗琴,等.血清胆红素及炎症指标与冠心病关系的探讨[J].中国循证心血管医学杂志,2018,10(7):805-809.[18]张应亮.血清尿酸和平均血小板体积对冠心病患者心血管事件的预测效果[J].广西医科大学学报,2018,35(2):253-255.[19]徐萍.血清胆红素与尿酸检测在冠心病诊断中的价值[J].检验医学与临床,2019,16(20):3047-3050.[20]王玲玲.血清胆红素与尿酸在冠心病患者临床检验中的价值[J].中国国境卫生检疫杂志,2022,45(1):149-151.[21]侯海瑞.血清胆红素与尿酸在冠心病患者临床检验中的效果及检出率分析[J].重庆医学,2021,50(2):272-275.[22]刘真成,边云飞.不稳定型心绞痛伴高血压病人血清尿酸及总胆红素水平的关系研究[J].中西医结合心脑血管病杂志,2019,17(15):2329-2331.[23]丁宁,陈长强,樊绮诗.红细胞分布宽度、血清总胆红素与冠心病及冠状动脉病变程度相关性研究[J].检验医学,2019,34(10):889-893.
相似文献/References:
[1]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Journal of Medical Information,2018,31(16):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[2]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Journal of Medical Information,2018,31(16):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[3]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Journal of Medical Information,2018,31(16):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[4]张 旭.冠心病心绞痛患者进行护理干预的临床效果及
对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Journal of Medical Information,2018,31(16):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[5]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Journal of Medical Information,2018,31(16):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[6]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与
冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Journal of Medical Information,2018,31(16):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[7]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Journal of Medical Information,2018,31(16):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[8]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Journal of Medical Information,2018,31(16):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[9]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Journal of Medical Information,2018,31(16):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[10]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Journal of Medical Information,2018,31(16):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
[11]王艳荣.血清胆红素、糖化血红蛋白联合血脂检验在2型糖尿病合并
冠心病诊断中的应用价值[J].医学信息,2019,32(16):165.[doi:10.3969/j.issn.1006-1959.2019.16.056]
WANG Yan-rong.Value of Serum Bilirubin and Glycosylated Hemoglobin Combined with Blood Lipid Test in the Diagnosis of Type 2 Diabetes Mellitus Complicated with Coronary Heart Disease[J].Journal of Medical Information,2019,32(16):165.[doi:10.3969/j.issn.1006-1959.2019.16.056]